Literature DB >> 35307107

Chemotherapy + PD-1/PD-L1 Blockade Should Be the Preferred Option in the Neoadjuvant Therapy of NSCLC.

Samuel Rosner1, Patrick M Forde2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35307107     DOI: 10.1016/j.jtho.2022.02.007

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

Review 1.  International expert consensus on immunotherapy for early-stage non-small cell lung cancer.

Authors:  Wenhua Liang; Kaican Cai; Qingdong Cao; Chun Chen; Haiquan Chen; Jun Chen; Ke-Neng Chen; Qixun Chen; Tianqing Chu; Yuchao Dong; Jiang Fan; Wentao Fang; Junke Fu; Xiangning Fu; Shugeng Gao; Di Ge; Guojun Geng; Qing Geng; Jie He; Jian Hu; Jie Hu; Wei-Dong Hu; Feng Jiang; Tao Jiang; Wenjie Jiao; He-Cheng Li; Qiang Li; Shanqing Li; Shuben Li; Xiangnan Li; Yong-De Liao; Changhong Liu; Hongxu Liu; Yang Liu; Zhuming Lu; Qingquan Luo; Haitao Ma; Xiaojie Pan; Guibin Qiao; Shengxiang Ren; Weiyu Shen; Yong Song; Daqiang Sun; Guangsuo Wang; Jie Wang; Mengzhao Wang; Qiwen Wang; Wen-Xiang Wang; Li Wei; Ming Wu; Nan Wu; Hui Xia; Shi-Dong Xu; Fan Yang; Kang Yang; Yue Yang; Fenglei Yu; Zhen-Tao Yu; Dong-Sheng Yue; Lanjun Zhang; Weidong Zhang; Zhenfa Zhang; Guofang Zhao; Jian Zhao; Xiaojing Zhao; Chengzhi Zhou; Qinghua Zhou; Kunshou Zhu; Yuming Zhu; Toyoaki Hida; Wolfram C M Dempke; Antonio Rossi; Marc de Perrot; Robert A Ramirez; Mariano Provencio; Jay M Lee; Antonio Passaro; Lorenzo Spaggiari; Jonathan Spicer; Nicolas Girard; Patrick M Forde; Tony S K Mok; Tina Cascone; Jianxing He
Journal:  Transl Lung Cancer Res       Date:  2022-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.